France Urology Supplements Market Size, Share, and COVID-19 Impact Analysis, By Type (Multi-Ingredient and Single-Ingredient), By Application (Urinary Tract Infections, Kidney Health, Prostate Health, Bladder Health, and Others), By Formulation (Capsules, Softgels, Tablets, Liquids, and Others), and France Urology Supplements Market Insights, Industry Trend, Forecasts to 2035

France Urology Supplements Market Insights Forecasts to 2035

• The France Urology Supplements Market Size Was Estimated at USD 57.98 Million in 2024
• The France Urology Supplements Market Size is Expected to Grow at a CAGR of Around 9.81% from 2025 to 2035
• The France Urology Supplements Market Size is Expected to Reach USD 162.23 Million by 2035

According to a research report published by Spherical Insights & Consulting, the France urology supplements market size is anticipated to reach USD 162.23 million by 2035, growing at a CAGR of 9.81% from 2025 to 2035. The France urology supplements market is driven by rising urinary and prostate health problems, an increasing aging population, growing awareness of preventive healthcare, and higher demand for natural and easy-to-use dietary supplements.

Market Overview

The France urology supplement market consists of dietary or nutritional products specifically formulated to promote good health amongst the urology system, including the urinary tract and prostate. Urology supplements are made from herbs, vitamins, and minerals and are commonly used to treat urinary discomfort resulting from benign prostatic hyperplasia and other conditions related to urology health. The growth of this market is being driven mainly by France's steadily increasing elderly population, growing awareness of preventive health care, and strong pharmacy and retail distribution in France.

Frances’s urology supplements market adoption is largely a consequence of the widespread occurrence of urological diseases, which are mainly attributable to an aging demographic. Close to 2 million France males have urinary problems associated with benign prostatic hyperplasia (BPH), while urinary tract disorders and bladder problems are frequently found in elderly women. More than 20% of the population in France is 65 years old or older, and consequently, increasing lower urinary tract symptoms, recurrent UTIs, and prostate-related discomfort are some of the reasons behind the expanding demand for preventive and supportive urology supplements in addition to regular treatments.

The market for urology supplements in France is ripe with potential due to factors such as increased health awareness, preventive nutrition demand, and a preference for wellness and non-prescription products. The government support is given indirectly through wider healthcare and research programs like France 2030 and Innovation Santé 2030, which, among other things, commit more than €7.5 billion to health innovation, prevention, and research, including nutrition and personalized health. National policies advocating for preventive care and research networks such as human nutrition research centers (CRNHs) that focus on health research provide further grounding for the development of evidence-based supplements, which, in turn, facilitate the long-term growth of the France urology supplements market.

Report Coverage

This research report categorizes the market for the France urology supplements market based on various segments and regions, and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France urology supplements market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France urology supplements market.

Driving Factors

The France urology supplements market is driven by the rising incidences of urological and prostate-related conditions that are mostly attributed to the aging population. The increasing awareness of preventive healthcare, inclination towards natural and non-pharmacological solutions, and provision through pharmacies and online channels have positively influenced the market. The growing consumer focus on urinary and prostate health also acts as a key factor contributing to demand escalation.

Restraining Factors

The France urology supplements market is restrained by a lack of clinical evidence for certain products and stringent regulations regarding health claims. Additionally, the market's growth is constrained by strong competition from prescription drugs and consumers' price sensitivity. Worries about product quality and effectiveness also have a negative impact on the rate of adoption.

Market Segmentation

The France urology supplements market share is classified into type, application, and formulation.

• The multi-ingredient segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France urology supplements market is segmented by type into multi-ingredient and single-ingredient. Among these, the multi-ingredient segment accounted for the largest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The multi-ingredient segmental growth is due to its ability to address multiple urological symptoms in a single formulation. These products offer greater convenience and perceived effectiveness. Growing consumer preference for comprehensive health solutions supports segment growth.

• The prostate health segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period.

The France urology supplements market is segmented by application into urinary tract infections, kidney health, prostate health, bladder health, and others. Among these, the prostate health segment dominated the market in 2024 and is anticipated to grow at a substantial CAGR during the forecast period. The prostate health segmental growth is due to the high prevalence of benign prostatic hyperplasia and other prostate disorders among France’s aging male population. Rising awareness of preventive urological care and strong demand for natural, long-term management supplements further support growth.

• The capsules segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. 

The France urology supplements market is segmented by formulation into capsules, softgels, tablets, liquids, and others. Among these, the capsules segment accounted for the largest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The capsules’ segmental growth is due to their ease of consumption, accurate dosage, and high consumer preference for convenient daily supplements. Additionally, better stability of active ingredients and wide availability across pharmacies and online channels in France support their dominant market share.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France urology supplements market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Bayer AG
• Sanofi S.A.
• Nestlé Health Science
• GSK Consumer Healthcare
• Pfizer Inc.
• Nature’s Bounty (The Bountiful Company)
• Jamieson Laboratories
• Solgar Inc.
• Arkopharma Laboratoires
• Laboratoires Vitarmonyl
• Biocyte
• Nutrilife France
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments:

• In July 2025, UroMems received clearance from both the U.S. FDA and France’s ANSM to begin a pivotal clinical trial of its UroActive smart implant for treating male stress urinary incontinence, marking a major advancement in urology solutions in France.

Market Segment

This study forecasts revenue at the Singapore, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France urology supplements market based on the below-mentioned segments:

France Urology Supplements Market, By Type

• Multi-ingredient
• Single-ingredient

France Urology Supplements Market, By Application

• Urinary Tract Infections
• Kidney Health
• Prostate Health
• Bladder Health
• Others

France Urology Supplements Market, By Formulation

• Capsules
• Softgels
• Tablets
• Liquids
• Others